HOB Biotech GroupLtd Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
John Li
Chief executive officer
CN¥2.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.4yrs |
| CEO ownership | 26.8% |
| Management average tenure | 1.8yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
HOB Biotech Group Corp.,Ltd's (SHSE:688656) Popularity With Investors Under Threat As Stock Sinks 29%
Dec 23
HOB Biotech GroupLtd's (SHSE:688656) Anemic Earnings Might Be Worse Than You Think
Nov 04Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 43%
Oct 08Subdued Growth No Barrier To HOB Biotech Group Corp.,Ltd's (SHSE:688656) Price
Jul 04HOB Biotech GroupLtd's (SHSE:688656) Earnings Are Weaker Than They Seem
May 06Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 25%
Mar 08CEO
John Li (61 yo)
7.4yrs
Tenure
CN¥1,989,000
Compensation
Mr. John Li serves as the Chairman & General Manager of HOB Biotech Group Co., Ltd and serves its Director since July 19, 2017. Mr. Li founded HOB Biotech in 2007. Mr. Li worked for multi-national corporat...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥1.99m | 26.76% CN¥ 1.7b | |
| Chief Financial Officer | 1.4yrs | CN¥692.00k | no data | |
| Deputy General Manager | 2.9yrs | CN¥1.42m | no data | |
| Director & Deputy GM | no data | CN¥2.33m | 0.00032% CN¥ 19.8k | |
| Secretary | 1.8yrs | CN¥542.00k | no data | |
| Deputy General Manager | no data | CN¥1.20m | no data |
1.8yrs
Average Tenure
50yo
Average Age
Experienced Management: 688656's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 7.4yrs | CN¥1.99m | 26.76% CN¥ 1.7b | |
| Director & Deputy GM | no data | CN¥2.33m | 0.00032% CN¥ 19.8k | |
| Vice Chairman of the Board | 11.2yrs | CN¥1.15m | 0.042% CN¥ 2.6m | |
| Chairman of the Supervisory Board | 7.4yrs | no data | no data | |
| Supervisor | 7.4yrs | no data | no data | |
| Supervisor | 3.6yrs | no data | no data | |
| Independent Director | 1.4yrs | CN¥19.00k | no data | |
| Independent Director | 1.4yrs | CN¥19.00k | no data | |
| Independent Director | 1.4yrs | CN¥19.00k | no data | |
| Director | 1.4yrs | CN¥1.13m | no data |
3.6yrs
Average Tenure
45.5yo
Average Age
Experienced Board: 688656's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 19:54 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HOB Biotech Group Corp.,Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|